Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue - Other
Ratios

Mereo BioPharma (MREO) Receivables - Other (2020 - 2023)

Mereo BioPharma (MREO) has disclosed Receivables - Other for 3 consecutive years, with $2.0 million as the latest value for Q4 2023.

  • Quarterly Receivables - Other changed N/A to $2.0 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2023, changed N/A year-over-year, with the annual reading at $2.0 million for FY2023, N/A changed from the prior year.
  • Receivables - Other for Q4 2023 was $2.0 million at Mereo BioPharma, up from $1.9 million in the prior quarter.
  • The five-year high for Receivables - Other was $2.0 million in Q4 2023, with the low at $853011.4 in Q4 2020.
  • Average Receivables - Other over 3 years is $1.6 million, with a median of $1.9 million recorded in 2021.
  • Peak annual rise in Receivables - Other hit 124.24% in 2021, while the deepest fall reached 124.24% in 2021.
  • Over 3 years, Receivables - Other stood at $853011.4 in 2020, then skyrocketed by 124.24% to $1.9 million in 2021, then rose by 1.94% to $2.0 million in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $2.0 million, $1.9 million, and $853011.4 for Q4 2023, Q4 2021, and Q4 2020 respectively.